Sun Pharmaceutical Industries Share Price Today - Live Blog for August 18, 2025

Sun Pharmaceutical Industries Ltd's stock has risen by a substantial 0.09%, and as of now, it's trading at ₹1,632.50 per share. This upward trajectory is attracting keen interest from investors.

The share price of Sun Pharmaceutical Industries Ltd soared by an impressive 0.11%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,632.50 per share.

Sun Pharmaceutical Industries Ltd experienced a -0.29% downturn in its share price, and it's currently trading at ₹1,630.80. This situation is generating interest among value investors who are evaluating the stock's potential.

Sun Pharmaceutical Industries Ltd shares saw a -0.05% decrease, reaching a current market price of ₹1,635.60. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 38.0000, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

After a notable 0.37% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,636.40. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.0327 and an ROE of 15.1334%.

In recent times, Sun Pharmaceutical Industries Ltd witnessed a decline of -0.04% in its share price, and it currently trades at ₹1,631.55 per share. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd's stock price surged by 0.10%, reaching the current market value of ₹1,632.20 per share. This surge is a testament to the stock's recent performance.

Sun Pharmaceutical Industries Ltd shares saw a decrease of -0.15%, reaching a current market price of ₹1,631.80. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Sun Pharmaceutical Industries Ltd's share price rallied by 0.01%, reaching the current market price of ₹1,634.20. This surge is indicative of the stock's recent positive performance.

After a -0.03% decline, Sun Pharmaceutical Industries Ltd shares are now trading at ₹1,634.00. The stock has a PE ratio of 38.0000, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd share price has declined by -0.09%, and it's currently trading at ₹1,633.55. The stock maintains a PE of 38.0000, while the industry PE is 34.8520, prompting discussions about its valuation.

Sun Pharmaceutical Industries Ltd's share price has dropped by -0.10%, a development that warrants careful analysis. Presently trading at ₹1,635.00, investors are assessing whether this presents an opportunity or a risk.

Sun Pharmaceutical Industries Ltd stock price decreased by -0.03%, with the current market value at ₹1,635.50 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Following a noteworthy 0.14% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,629.65. When it comes to valuation, this stock has a PE ratio of 38.0000, with the industry PE ratio at 34.8520.

The share price of Sun Pharmaceutical Industries Ltd recently experienced a positive upturn, resulting in a 0.14% increase. Presently, it is actively trading at ₹1,629.65.

The share price of Sun Pharmaceutical Industries Ltd plunged by -0.12%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,628.10, but investors are assessing whether this is a temporary dip or a long-term trend.

In recent times, Sun Pharmaceutical Industries Ltd witnessed a decline of -0.32% in its share price, and it currently trades at ₹1,627.50 per share. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd witnessed a -0.32% decrease in its share price, and it is currently trading at ₹1,627.50. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 38.0000, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd witnessed a -0.17% drop in its share price and is currently trading at ₹1,632.70. With the stock's PE at 38.0000 and the industry PE at 34.8520, investors are weighing their options.

Sun Pharmaceutical Industries Ltd witnessed a -0.09% decrease in its share price, and it is currently trading at ₹1,635.15. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 38.0000, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd witnessed a substantial 0.17% increase in its share price and is currently trading at ₹1,636.65. This remarkable performance has caught the eye of investors.

Sun Pharmaceutical Industries Ltd's share price has dropped by -0.12%, a development that warrants careful analysis. Presently trading at ₹1,634.00, investors are assessing whether this presents an opportunity or a risk.

Sun Pharmaceutical Industries Ltd experienced a -0.13% downturn in its share price, and it's currently trading at ₹1,635.10. This situation is generating interest among value investors who are evaluating the stock's potential.

Sun Pharmaceutical Industries Ltd's shares saw an increase of 0.02%, reaching the current market price of ₹1,636.35. This development underscores the stock's growing popularity.

With a remarkable 0.15% increase in value, the share price of Sun Pharmaceutical Industries Ltd currently stands at ₹1,638.10. Notably, this stock has a Price-to-Earnings (PE) ratio of 38.0000, while the industry's PE ratio is 34.8520.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.22% decline, and it currently trades at ₹1,638.00 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.